These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33642171)

  • 1. Missed Opportunities to Initiate Oral Anticoagulant in Atrial Fibrillation: Insights from Australian Acute Coronary Syndrome Registries.
    Ma M; Hyun K; D'Souza M; Chew D; Brieger D
    Heart Lung Circ; 2021 Aug; 30(8):1157-1165. PubMed ID: 33642171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
    Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
    BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?
    Fake AL; Harding SA; Matsis PP; Larsen PD
    N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.
    Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
    JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39).
    Ho CY; Nunn C; White J; Kerr A; Lee M
    N Z Med J; 2020 Jul; 133(1519):41-54. PubMed ID: 32777794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
    Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
    Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
    Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
    Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Therapy in Atrial Fibrillation Management in Western Australia: Temporal Trends and Evidence-Treatment Gaps.
    Hutchens R; Hung J; Briffa T; McQuillan B
    Heart Lung Circ; 2021 Jul; 30(7):955-962. PubMed ID: 33386242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
    Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
    JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.